Eli Lilly and India’s Cipla enter deal on diabetes treatments
October 4, 2021Business Services, Sales and Marketing
Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling …
FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu
October 4, 2021Research and Development, Sales and Marketing
AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …
Faron raises over €10mln to support key drug candidates
October 1, 2021Medical Communications
Clinical stage biopharmaceutical company, Faron, has raised €10.5mln through a placing of new shares backed by the European Innovation Council …
Delta variant found to be common in children across US
October 1, 2021Medical Communications
School-aged children across the US are being exposed to the increasingly prevalent Delta variant of COVID-19. This is linked to …
New Gyros kit supports cell and gene therapy
October 1, 2021Medical Communications
Gyros Protein Technologies, leading provider of peptide synthesisers and reagents, has introduced the Gyrolab® AAV9 Titer Kit to support AAV-based …
Takeda: Stainless steel COVID vaccine contamination due to human error
October 1, 2021Medical Communications
Takeda has said that “human error” led to metal contaminants being present in Moderna’s COVID-19 vaccine doses, which caused around …
GSK and Merck KGaA end collaboration on cancer drug hopeful
October 1, 2021Medical Communications
GSK and German based Merck KGaA announced on Thursday that they have ended their collaboration on cancer treatment bintrafusp alfa, …
EADV reveals vaccine hesitancy in psoriasis patients
September 30, 2021Business Services
Research presented at the European Academy of Dermatology and Venerology (EADV) 30th Congress has revealed that psoriasis and psoriatic arthritic …
Nanoform granted funding to tackle global health challenges
September 30, 2021Business Services
Innovative nanoparticle medicine company, Nanoform, has announced that proof of concept studies will receive funding from the Bill & Melinda …
MSD pioneers gender-neutral HPV vaccine in India
September 30, 2021Business Services
MSD Pharmaceuticals has announced the launch of India’s first gender-neutral Human Papillomavirus (HPV) vaccine, according to ABP Live. The aim …
Study finds coming off antidepressants may not cause relapse
September 30, 2021Researchers from the universities of York, Southampton, and Bristol, UCL, and McMaster University in Canada, have been investigating the impacts …
Mirum’s Livmarli becomes first US approved Alagille syndrome treatment
September 30, 2021Mirum Pharmaceutical’s oral drug has become the first approved treatment for treating itching in patients with a rare liver disorder …
Avacta reaches milestone in LG Chem partnership
September 29, 2021Research and Development
Clinical stage biopharmaceutical company, Avacta Group plc, has announced that a preclinical development milestone has been achieved in the partnership …
Novartis autoinjector effective for treating psoriasis
September 29, 2021Research and Development
New data show that Novartis Cosentyx (secukinumab) 300-mg single dose autoinjector resulted in high efficacy vs placebo. Cosentyx is a …
Acacia Pharma’s new cancer care injection approved in Europe
September 29, 2021Research and Development
Biopharmaceutical company Acacia Pharma Group plc (Acacia Pharma) has announced that its Marketing Authorisation Application (MAA) for BARHEMSYS® (amisulpride injection) …
Vitamin A nasal spray being trialled for COVID smell loss
September 29, 2021Research and Development
The University of East Anglia is conducting a 12-week trial to investigate the use of vitamin A nasal spray to …
Several rival companies set to launch antiviral pills for COVID-19
September 29, 2021Research and Development
With Merck and Pfizer preparing to release clinical trial results from its experimental COVID-19 antiviral pills, rivals are lining up …
Debunking vaccine myths and growing concerns
September 28, 2021Manufacturing and Production
Before the COVID-19 pandemic, vaccines were never seen as a quick fix. Preventative vaccines for Ebola, malaria, and the Zika …
ViroCell Biologics announces pivotal partnership with Great Ormond Street
September 28, 2021Manufacturing and Production
Innovation-driven viral vector manufacturer, ViroCell Biologics, and Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), have announced a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
